Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 079171
Company: SANDOZ

Products on ANDA 079171

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET;ORAL	Discontinued	None	No	No
ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET;ORAL	Discontinued	None	No	No
ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET;ORAL	Discontinued	None	No	No
ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 079171

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/19/2016	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/079171Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/19/2024	SUPPL-15	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.
11/22/2023	SUPPL-14	Labeling-Patient Package Insert, Labeling-Package Insert		Label is not available on this site.
07/13/2023	SUPPL-13	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.
07/13/2023	SUPPL-7	Labeling-Patient Package Insert, Labeling-Package Insert		Label is not available on this site.
07/13/2023	SUPPL-6	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.
03/09/2020	SUPPL-5	Labeling-Package Insert		Label is not available on this site.
03/09/2020	SUPPL-2	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.